David Jin
Director of Finance/CFO at AVENUE THERAPEUTICS, INC.
Net worth: 304 038 $ as of 2024-03-30
Profile
David Jin is currently the CFO, CAO & Head of Corporate Development at Fortress Biotech, Inc. He is also the Secretary, Chief Operating & Financial Officer at Avenue Therapeutics, Inc. starting in 2022.
Previously, he worked as the Director-Corporate Development at Sorrento Therapeutics, Inc. and as the Vice President-Healthcare Investment Banking at FBR & Co. Mr. Jin completed his undergraduate degree at Northwestern University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
FORTRESS BIOTECH, INC.
0.83% | 2024-03-31 | 152,019 ( 0.83% ) | 304 038 $ | 2024-03-30 |
2024-01-08 | 0 ( -.--% ) | - $ | 2024-03-30 |
David Jin active positions
Companies | Position | Start |
---|---|---|
AVENUE THERAPEUTICS, INC. | Director of Finance/CFO | 2022-05-10 |
FORTRESS BIOTECH, INC. | Director of Finance/CFO | 2022-08-15 |
Former positions of David Jin
Companies | Position | End |
---|---|---|
FBR & CO | Corporate Officer/Principal | - |
SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of David Jin
Northwestern University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
FORTRESS BIOTECH, INC. | Health Technology |
SORRENTO THERAPEUTICS, INC. | Health Technology |
AVENUE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
FBR & Co.
FBR & Co. Investment Banks/BrokersFinance FBR & Co. provides investment banking, merger and acquisition advisory, institutional brokerage and research services through its subsidiaries. The company operates through two segments: Capital Markets and Principal Investing. The Capital Markets segment includes investment banking, institutional brokerage and research. It also provides investment banking services, including capital raising and financial advisory services for its corporate issuer clients, and institutional brokerage services including sales, trading, research, and securities lending services to its institutional investor clients. The Principal Investing segment activities consist primarily of investments in merchant banking and other equity investments, investment funds and corporate debt investments. The company was founded in June 2006 and is headquartered in Arlington, VA. | Finance |
- Stock Market
- Insiders
- David Jin